Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1967 Jul;107(1):33–46.

Pressor agents.

N T Smith
PMCID: PMC1502847  PMID: 4859720

Full text

PDF
33

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALDINGER E. E. EFFECTS OF SEVERAL CARDIOVASCULAR DRUGS ON VARIOUS PHASES OF CIRCULATORY DYNAMICS. Am Heart J. 1964 Jul;68:55–65. doi: 10.1016/0002-8703(64)90240-6. [DOI] [PubMed] [Google Scholar]
  2. ALI H. I., ANTONIO A., HAUGAARD N. THE ACTION OF SYMPATHOMIMETIC AMINES AND ADRENERGIC BLOCKING AGENTS ON TISSUE PHOSPHORYLASE ACTIVITY. J Pharmacol Exp Ther. 1964 Aug;145:142–150. [PubMed] [Google Scholar]
  3. ANDERSEN T. W., GRAVENSTEIN J. S. MEPHENTERMINE AND EPHEDRINE IN MAN; A COMPARATIVE STUDY ON CARDIOVASCULAR EFFECTS. Clin Pharmacol Ther. 1964 May-Jun;5:281–285. doi: 10.1002/cpt196453281. [DOI] [PubMed] [Google Scholar]
  4. AVIADO D. M., Jr, SCHMIDT C. F. Effects of sympathomimetic drugs on pulmonary circulation: with special reference to a new pulmonary vasodilator. J Pharmacol Exp Ther. 1957 Aug;120(4):512–527. [PubMed] [Google Scholar]
  5. AVIADO D. M. PHARMACOLOGIC APPROACH TO THE TREATMENT OF SHOCK. Ann Intern Med. 1965 May;62:1050–1059. doi: 10.7326/0003-4819-62-5-1050. [DOI] [PubMed] [Google Scholar]
  6. Altura B. M., Hershey S. G., Mazzia V. D. Microcirculatory approach to vasopressor therapy in intestinal ischemic (SMA) shock. Am J Surg. 1966 Feb;111(2):186–192. doi: 10.1016/0002-9610(66)90236-4. [DOI] [PubMed] [Google Scholar]
  7. BAGWELL E. E., WOODS E. F., DURST G. G., Jr INFLUENCE OF RESERPINE ON CARDIOVASCULAR AND SYMPATHO-ADRENAL RESPONSES TO CYCLOPROPANE ANESTHESIA IN THE DOG. Anesthesiology. 1964 Mar-Apr;25:148–155. doi: 10.1097/00000542-196403000-00007. [DOI] [PubMed] [Google Scholar]
  8. BARRERA F., LYNCH P. R., OPPENHEIMER M. J., STEWART G. H., 3rd Changes in properties of heart muscle due to mephentermine. Am J Physiol. 1956 Sep;186(3):513–517. doi: 10.1152/ajplegacy.1956.186.3.513. [DOI] [PubMed] [Google Scholar]
  9. BENDIXEN H. H., OSGOOD P. F., HALL K. V., LAVER M. B. DOSE-DEPENDENT DIFFERENCES IN CATECHOLAMINE ACTION ON HEART AND PERIPHERY. J Pharmacol Exp Ther. 1964 Sep;145:299–306. [PubMed] [Google Scholar]
  10. BERNSTEIN A., SIMON F., ROTHFELD E. J., ROBINS B., COHEN F. B., KAUFMAN J. G. Treatment of shock in myocardial infarction. Am J Cardiol. 1962 Jan;9:74–81. doi: 10.1016/0002-9149(62)90099-1. [DOI] [PubMed] [Google Scholar]
  11. BERRY W. B., AUSTEN W. G., CLARK W. D. STUDIES ON THE RELATIVE CARDIAC AND PERIPHERAL ACTIONS OF ANGIOTENSIN. Ann Surg. 1964 Apr;159:520–528. doi: 10.1097/00000658-196404000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. BIANCHI A., DE SCHAEPDRYVER A. F., DE VLEESCHHOUWER G. R., PREZIOSI P. On the pharmacology of synthetic hypertensine. Arch Int Pharmacodyn Ther. 1960 Feb 1;124:21–44. [PubMed] [Google Scholar]
  13. BLOCH J. H., PIERCE C. H., MANAX W. G., LILLEHEI R. C. TREATMENT OF EXPERIMENTAL CARDIOGENIC SHOCK. Surgery. 1965 Jul;58:197–214. [PubMed] [Google Scholar]
  14. BRAUNWALD E., CHIDSEY C. A., HARRISON D. C., GAFFNEY T. E., KAHLER R. L. STUDIES ON THE FUNCTION OF THE ADRENERGIC NERVE ENDINGS IN THE HEART. Circulation. 1963 Nov;28:958–969. doi: 10.1161/01.cir.28.5.958. [DOI] [PubMed] [Google Scholar]
  15. BRODIE B. B. RECENT VIEWS ON MECHANISMS FOR LOWERING SYMPATHETIC TONE. Circulation. 1963 Nov;28:970–986. doi: 10.1161/01.cir.28.5.970. [DOI] [PubMed] [Google Scholar]
  16. BROFMAN B. L., HELLERSTEIN H. K., CASKEY W. H. Mephentermine: an effective pressor amine; clinical and laboratory observations. Am Heart J. 1952 Sep;44(3):396–406. doi: 10.1016/0002-8703(52)90261-5. [DOI] [PubMed] [Google Scholar]
  17. BRYANT M. F., HOWARD J. M. Necrotizing properties of metaraminol (aramine) and arterenol (norepinephrine); comparative study. AMA Arch Surg. 1957 Dec;75(6):1020–1022. doi: 10.1001/archsurg.1957.01280180152023. [DOI] [PubMed] [Google Scholar]
  18. BURN J. H., RAND M. J. Fall of blood pressure after a noradrenaline infusion and its treatment by pressor agents. Br Med J. 1959 Feb 14;1(5119):394–397. doi: 10.1136/bmj.1.5119.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. BURN J. H., RAND M. J. The action of sympathomimetic amines in animals treated with reserpine. J Physiol. 1958 Dec 4;144(2):314–336. doi: 10.1113/jphysiol.1958.sp006104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Binder M. J. Effect of vasopressor drugs on circulatory dynamics in shock following myocardial infarction. Am J Cardiol. 1965 Dec;16(6):834–840. doi: 10.1016/0002-9149(65)90701-0. [DOI] [PubMed] [Google Scholar]
  21. Botticelli J. T., Tsagaris T. J., Lange R. L. Mechanisms of pressor amine dependence. Am J Cardiol. 1965 Dec;16(6):847–858. doi: 10.1016/0002-9149(65)90703-4. [DOI] [PubMed] [Google Scholar]
  22. Brown E., Goei J. S., Greenfield A. D., Plassaras G. C. Circulatory responses to simulated gravitational shifts of blood in man induced by exposure of the body below the iliac crests to sub-atmospheric pressure. J Physiol. 1966 Apr;183(3):607–627. doi: 10.1113/jphysiol.1966.sp007887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. COAKLEY C. S., ALPERT S., BOLING J. S. Circulatory responses during anesthesia of patients on Rauwolfia therapy. J Am Med Assoc. 1956 Jul 21;161(12):1143–1144. doi: 10.1001/jama.1956.02970120025007. [DOI] [PubMed] [Google Scholar]
  24. COLON-YORDAN E., JIMENEZ-VELEZ J. L. Effects of intravenous atropine and scopolamine during cyclopropanesuccinylcholine anesthesia. Anesthesiology. 1962 May-Jun;23:333–341. [PubMed] [Google Scholar]
  25. COVINO B. G. Autifibrillary effect of mephentermine sulfate (wyamine) in general hypothermia. J Pharmacol Exp Ther. 1958 Mar;122(3):418–422. [PubMed] [Google Scholar]
  26. COVINO B. G., MARGOLIS N., D'AMATO H. E. Effect of various drugs on spontaneous and surgically induced ventricular fibrillation in hypothermia. Am Heart J. 1959 Nov;58:750–754. doi: 10.1016/0002-8703(59)90234-0. [DOI] [PubMed] [Google Scholar]
  27. CRANDELL D. L. The anesthetic hazards in patients on antihypertensive therapy. JAMA. 1962 Feb 17;179:495–500. doi: 10.1001/jama.1962.03050070017004. [DOI] [PubMed] [Google Scholar]
  28. CROUT J. R., ALPERS H. S., TATUM E. L., SHORE P. A. RELEASE OF METARAMINOL (ARAMINE) FROM THE HEART BY SYMPATHETIC NERVE STIMULATION. Science. 1964 Aug 21;145(3634):828–829. doi: 10.1126/science.145.3634.828. [DOI] [PubMed] [Google Scholar]
  29. CUMMINGS J. R., HAYS H. W. Cardiovascular studies of adrenergic and ganglionic stimulating drugs administered during cyclopropane. Anesthesiology. 1956 Mar;17(2):314–324. doi: 10.1097/00000542-195603000-00011. [DOI] [PubMed] [Google Scholar]
  30. Cronin R. F., Moore S., Marpole D. G. Shock Following Myocardial Infarction: A Clinical Survey of 140 Cases. Can Med Assoc J. 1965 Jul 10;93(2):57–63. [PMC free article] [PubMed] [Google Scholar]
  31. DARBY T. D., ALDINGER E. E., GADSDEN R. H., THROWER W. B. Effects of metabolic acidosis on ventricular isometric systolic tension and the response to epinephrine and levarterenol. Circ Res. 1960 Nov;8:1242–1253. doi: 10.1161/01.res.8.6.1242. [DOI] [PubMed] [Google Scholar]
  32. DUKE M., AMES R. P., ABELMANN W. H. HEMODYNAMIC EFFECTS OF METHOXAMINE IN NORMAL HUMAN SUBJECTS. Am J Med Sci. 1963 Sep;246:301–307. doi: 10.1097/00000441-196309000-00007. [DOI] [PubMed] [Google Scholar]
  33. DUNER H., VON EULER U. S. Secondary fall in blood pressure following noradrenaline infusion in the cat. Acta Physiol Scand. 1957 Mar 7;38(3-4):355–363. doi: 10.1111/j.1748-1716.1957.tb01397.x. [DOI] [PubMed] [Google Scholar]
  34. Dagher F. J., Lyons J. H., Lister J., Moore F. D. Hemorrhage in normal man. The effects of angiotensin. J Surg Res. 1966 Feb;6(2):66–73. doi: 10.1016/s0022-4804(66)80073-2. [DOI] [PubMed] [Google Scholar]
  35. EAKINS K. E., LOCKETT M. F. The formation of an isoprenaline-like substance from adrenaline. Br J Pharmacol Chemother. 1961 Feb;16:108–115. doi: 10.1111/j.1476-5381.1961.tb00303.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. ECKFELD D. K., ABELL L. L., SEIFTER J. Pharmacological properties of mephentermine, a sympathomimetic amine. J Am Pharm Assoc Am Pharm Assoc. 1954 Dec;43(12):705–708. doi: 10.1002/jps.3030431202. [DOI] [PubMed] [Google Scholar]
  37. EGER E. I., 2nd Atropine, scopolamine, and related compounds. Anesthesiology. 1962 May-Jun;23:365–383. doi: 10.1097/00000542-196205000-00012. [DOI] [PubMed] [Google Scholar]
  38. ELLIS C. H. CONTROL OF VENTRICULAR TACHYCARDIAS IN DOGS BY B.W. 62-235, A DERIVATIVE OF METHOXAMINE. Arch Int Pharmacodyn Ther. 1964 Jul 1;150:144–154. [PubMed] [Google Scholar]
  39. ELLIS C. H. INFLUENCE OF CERTAIN PHENYLALKYLAMINES ON DEPRESSION OF CARDIAC CONTRACTILITY BY CALCIUM CHELATERS. Arch Int Pharmacodyn Ther. 1965 Mar;154:26–39. [PubMed] [Google Scholar]
  40. FAWAZ G. The effect of mephentermine on isolated dog hearts, normal and pretreated with reserpine. Br J Pharmacol Chemother. 1961 Jun;16:309–314. doi: 10.1111/j.1476-5381.1961.tb01089.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. FERRANS V. J., HIBBS R. G., BLACK W. C., WEILBAECHER D. G. ISOPROTERENOL-INDUCED MYOCARDIAL NECROSIS. A HISTOCHEMICAL AND ELECTRON MICROSCOPIC STUDY. Am Heart J. 1964 Jul;68:71–90. doi: 10.1016/0002-8703(64)90242-x. [DOI] [PubMed] [Google Scholar]
  42. FINNERTY F. A., Jr Hemodynamics of angiotensin in man. Circulation. 1962 Jan;25:255–258. doi: 10.1161/01.cir.25.1.255. [DOI] [PubMed] [Google Scholar]
  43. FOWLER N. O., HOLMES J. C. CORONARY AND MYOCARDIAL ACTIONS OF ANGIOTENSIN. Circ Res. 1964 Mar;14:191–201. doi: 10.1161/01.res.14.3.191. [DOI] [PubMed] [Google Scholar]
  44. FREIHEIT H. J. Preliminary observations on the positive inotropic effects of mephentermine. Int Rec Med Gen Pract Clin. 1957 Sep;170(9):510–514. [PubMed] [Google Scholar]
  45. FRYE R. L., BRAUNWALD E. Studies on Starling's law of the heart. I. The circulatory response to acute hypervolemia and its modification by ganglionic blockade. J Clin Invest. 1960 Jul;39:1043–1050. doi: 10.1172/JCI104119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. GAZES P. C., GOLDBERG L. I., DARBY T. D. Heart force effects of sympathomimetic amines as a basis for their use in shock accompanying myocardial infarction. Circulation. 1953 Dec;8(6):883–892. doi: 10.1161/01.cir.8.6.883. [DOI] [PubMed] [Google Scholar]
  47. GILBERT J. L., LANGE G., BROOKS C. M. Influence of sympathomimetic pressor drugs on arrhythmias caused by multiple stimuli. Circ Res. 1959 May;7(3):417–423. doi: 10.1161/01.res.7.3.417. [DOI] [PubMed] [Google Scholar]
  48. GILBERT J. L., LANGE G., POLEVOY I., BROOKS C. M. Effects of vasoconstrictor agents on cardiac irritability. J Pharmacol Exp Ther. 1958 May;123(1):9–15. [PubMed] [Google Scholar]
  49. GLASSMAN J. M., SEIFTER J. The effect of mephentermine on hypodynamic and arrhythmic isolated frog hearts. J Pharmacol Exp Ther. 1954 Nov;112(3):364–373. [PubMed] [Google Scholar]
  50. GOLDBERG L. I., BLOODWELL R. D., BRAUNWALD E., MORROW A. G. The direct effects of norepinephrine, epinephrine, and methoxamine on myocardial contractile force in man. Circulation. 1960 Dec;22:1125–1132. doi: 10.1161/01.cir.22.6.1125. [DOI] [PubMed] [Google Scholar]
  51. GOLDFIEN A. PHEOCHROMOCYTOMA: DIAGNOSIS AND ANESTHETIC AND SURGICAL MANAGEMENT. Anesthesiology. 1963 Jul-Aug;24:462–471. [PubMed] [Google Scholar]
  52. GREEN H. D., BLUMBERG J. B. THE USE OF A SYNTHETIC ANALOGUE OF POSTHYPOPHYSIAL VASOPRESSIN (PLV-2) FOR LOCAL HEMOSTASIS. Surgery. 1965 Sep;58:524–529. [PubMed] [Google Scholar]
  53. HAMELBERG W., BOSOMWORTH P. P. Evaluation of ephedrine test. JAMA. 1963 Mar 2;183:782–783. doi: 10.1001/jama.1963.63700090028016. [DOI] [PubMed] [Google Scholar]
  54. HAMIT H. F. CURRENT TRENDS OF THERAPY AND RESEARCH IN SHOCK. Surg Gynecol Obstet. 1965 Apr;120:835–854. [PubMed] [Google Scholar]
  55. HARRISON D. C., GLICK G., GOLDBLATT A., BRAUNWALD E. STUDIES ON CARDIAC DIMENSIONS IN INTACT, UNANESTHETIZED MAN. IV. EFFECTS OF ISOPROTERENOL AND METHOXAMINE. Circulation. 1964 Feb;29:186–194. doi: 10.1161/01.cir.29.2.186. [DOI] [PubMed] [Google Scholar]
  56. HERSHEY S. G. DYNAMICS OF PERIPHERAL VASCULAR COLLAPSE IN SHOCK. Int Anesthesiol Clin. 1964 Feb;2:185–200. doi: 10.1097/00004311-196402000-00004. [DOI] [PubMed] [Google Scholar]
  57. HINGSON R. A., DAVIS H. S., INMAN C. E., LELIEVRE R. E. A clinical evaluation of mephentermine as a vasopressor in surgery and obstetrics. Am Pract Dig Treat. 1955 Jul;6(7):1004–1014. [PubMed] [Google Scholar]
  58. Haefely W., Hürlimann A., Thoenen H. The effect of stimulation of sympathetic nerves in the cat treated with reserpine, alpha-methyldopa and alpha-methylmetatyrosine. Br J Pharmacol Chemother. 1966 Jan;26(1):172–185. doi: 10.1111/j.1476-5381.1966.tb01819.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Hong E., Mendoza P. A., Pardo E. G. Influence of previous reserpine administration on the ganglionic action of selected sympathomimetic amines. Life Sci. 1965 Dec;4(24):2383–2392. doi: 10.1016/0024-3205(65)90293-6. [DOI] [PubMed] [Google Scholar]
  60. IMAI S., SHIGEI T., HASHIMOTO K. Cardiac actions of methoxamine with special reference to its antagonistic action to epinephrine. Circ Res. 1961 May;9:552–560. doi: 10.1161/01.res.9.3.552. [DOI] [PubMed] [Google Scholar]
  61. JACOBSON E., ADELMAN M. H. The electrocardiographic effects of intravenous administration of neostigmine and atropine during cyclopropane anesthesia. Anesthesiology. 1954 Jul;15(4):407–415. doi: 10.1097/00000542-195407000-00008. [DOI] [PubMed] [Google Scholar]
  62. JOHNSON W. P., BRUCE R. A. Hemodynamic and metabolic effects of angiotensin II during rest and exercise in normal healthy subjects. Am Heart J. 1962 Feb;63:212–218. doi: 10.1016/0002-8703(62)90197-7. [DOI] [PubMed] [Google Scholar]
  63. JOHNSTONE M. The cardiology of anaesthesia. Curr Res Anesth Analg. 1952 Sep-Oct;31(5):325–331. [PubMed] [Google Scholar]
  64. James T. N. Absence of direct chronotropic action of angiotensin infused into the sinus node artery. Am J Physiol. 1965 Sep;209(3):571–576. doi: 10.1152/ajplegacy.1965.209.3.571. [DOI] [PubMed] [Google Scholar]
  65. KARIM S. M. SYMPATHETIC BETA-RECEPTOR BLOCKING ACTION OF METHOXAMINE. Br J Pharmacol Chemother. 1965 Apr;24:365–374. doi: 10.1111/j.1476-5381.1965.tb01724.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. KOCH-WESER J. MYOCARDIAL ACTIONS OF ANGIOTENSIN. Circ Res. 1964 Apr;14:337–344. doi: 10.1161/01.res.14.4.337. [DOI] [PubMed] [Google Scholar]
  67. KOCH-WESER J. NATURE OF THE INOTROPIC ACTION OF ANGIOTENSIN ON VENTRICULAR MYOCARDIUM. Circ Res. 1965 Mar;16:230–237. doi: 10.1161/01.res.16.3.230. [DOI] [PubMed] [Google Scholar]
  68. KOLOMEYER N. A clinical evaluation of mephentermine sulfate and pentylenetetrazol as stimulant therapy for the geriatric patient. J Am Geriatr Soc. 1958 May;6(5):415–423. doi: 10.1111/j.1532-5415.1958.tb00736.x. [DOI] [PubMed] [Google Scholar]
  69. KOPIN I. J., FISCHER J. E., MUSACCHIO J. M., HORST W. D., WEISE V. K. "FALSE NEUROCHEMICAL TRANSMITTERS" AND THE MECHANISM OF SYMPATHETIC BLOCKADE BY MONOAMINE OXIDASE INHIBITORS. J Pharmacol Exp Ther. 1965 Feb;147:186–193. [PubMed] [Google Scholar]
  70. KROGSGAARD A. R. The effect of intravenously injected reserpine on blood pressure, renal function and sodium excretion. Acta Med Scand. 1956 Mar 8;154(1):41–51. doi: 10.1111/j.0954-6820.1956.tb14298.x. [DOI] [PubMed] [Google Scholar]
  71. Krasney J. A., Paudler F. T., Smith D. C., Davis L. D., Youmans W. B. Mechanisms of cardioaccelerator action of angiotensin. Am J Physiol. 1965 Sep;209(3):539–544. doi: 10.1152/ajplegacy.1965.209.3.539. [DOI] [PubMed] [Google Scholar]
  72. LAHTI R. E., BRILL I. C., MCCAWLEY E. L. The effect of methoxamine hydrochloride (vasoxyl) on cardiac rhythm. J Pharmacol Exp Ther. 1955 Nov;115(3):268–274. [PubMed] [Google Scholar]
  73. LANDS A. M., BROWN T. G., Jr A COMPARISON OF THE CARDIAC STIMULATING AND BRONCHODILATOR ACTIONS OF SELECTED SYMPATHOMIMETIC AMINES. Proc Soc Exp Biol Med. 1964 Jun;116:331–333. doi: 10.3181/00379727-116-29239. [DOI] [PubMed] [Google Scholar]
  74. LEVER A. F., MOWBRAY J. F., PEART W. S. Blood flow and blood pressure after noradrenaline infusions. Clin Sci. 1961 Aug;21:69–74. [PubMed] [Google Scholar]
  75. LEVY B. ALTERATIONS OF ADRENERGIC RESPONSES BY N-ISOPROPYLMETHOXAMINE. J Pharmacol Exp Ther. 1964 Oct;146:129–138. [PubMed] [Google Scholar]
  76. LILLEHEI R. C., LONGERBEAM J. K., BLOCH J. H., MANAX W. G. THE MODERN TREATMENT OF SHOCK BASED ON PHYSIOLOGIC PRINCIPLES. Clin Pharmacol Ther. 1964 Jan-Feb;5:63–101. doi: 10.1002/cpt19645163. [DOI] [PubMed] [Google Scholar]
  77. LILLEHEI R. C., LONGERBEAM J. K., BLOCH J. H., MANAX W. G. THE NATURE OF EXPERIMENTAL IRREVERSIBLE SHOCK WITH ITS CLINICAL APPLICATION. Int Anesthesiol Clin. 1964 Feb;2:297–363. doi: 10.1097/00004311-196402000-00011. [DOI] [PubMed] [Google Scholar]
  78. LILLEHEI R. C., LONGERBEAM J. K., BLOCH J. H., MANAX W. G. THE NATURE OF IRREVERSIBLE SHOCK: EXPERIMENTAL AND CLINICAL OBSERVATIONS. Ann Surg. 1964 Oct;160:682–710. doi: 10.1097/00000658-196410000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. LISTER J., MCNEILL I. F., MARSHALL V. C., PLZAK L. F., Jr, DAGHER F. J., MOORE F. D. TRANSCAPILLARY REFILLING AFTER HEMORRHAGE IN NORMAL MAN: BASAL RATES AND VOLUMES; EFFECT OF NOREPINEPHRINE. Ann Surg. 1963 Oct;158:698–712. doi: 10.1097/00000658-196310000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. LI T. H., SHIMOSATO S., ETSTEN B. Hemodynamics of mephentermine in man. N Engl J Med. 1962 Jul 26;267:180–184. doi: 10.1056/NEJM196207262670404. [DOI] [PubMed] [Google Scholar]
  81. LI T. H., SHIMOSATO S., GAMBLE C. A., ETSTEN B. E. HEMODYNAMICS OF MEPHENTERMINE DURING SPINAL ANESTHESIA IN MAN. Anesthesiology. 1963 Nov-Dec;24:817–827. doi: 10.1097/00000542-196311000-00012. [DOI] [PubMed] [Google Scholar]
  82. LUNDBERG A. Adrenaline and transmission in the sympathetic ganglion of the cat. Acta Physiol Scand. 1952 Sep 10;26(2-3):252–263. doi: 10.1111/j.1748-1716.1952.tb00908.x. [DOI] [PubMed] [Google Scholar]
  83. LURIA M. H., MILLER A. J., KAPLAN B. M. SUCCESSFUL THERAPY OF PROLONGED HYPOTENSION WITH AN ADRENERGIC BETA-RECEPTOR BLOCKING AGENT. Circulation. 1964 Apr;29:SUPPL–SUPPL:498. doi: 10.1161/01.cir.29.4.494. [DOI] [PubMed] [Google Scholar]
  84. LYNCH P. R., WEBBER D. L., OPPENHEIMER M. J. Mephentermine as an antifibrillatory drug against cyclopropane-epinephrine ventricular fibrillation. Anesthesiology. 1955 Jul;16(4):632–642. doi: 10.1097/00000542-195507000-00020. [DOI] [PubMed] [Google Scholar]
  85. MARSTON E. L., BAREFOOT C. A., SPENCER M. P. Non-cannulating measurement of coronary blood flow. Surg Forum. 1960;10:636–639. [PubMed] [Google Scholar]
  86. MATTHEWS R. J., Jr The effect of epinephrine, levarterenol, and dl-isoproterenol on transmission in the superior cervical ganglion of the cat. J Pharmacol Exp Ther. 1956 Apr;116(4):433–443. [PubMed] [Google Scholar]
  87. MAZURKIEWICZ I. M., MURNAGHAN M. F. NORADRENALINE POSTINFUSIONAL HYPOTENSION. Arch Int Pharmacodyn Ther. 1964 Mar 1;148:186–199. [PubMed] [Google Scholar]
  88. MINUCK M. Reaction to drugs during surgery and anaesthesia. Can Med Assoc J. 1960 May 14;82:1008–1011. [PMC free article] [PubMed] [Google Scholar]
  89. MORAN N. C. ADRENERGIC RECEPTORS WITHIN THE CARDIOVASCULAR SYSTEM. Circulation. 1963 Nov;28:987–993. doi: 10.1161/01.cir.28.5.987. [DOI] [PubMed] [Google Scholar]
  90. MUNSON W. M., JENICEK J. A. Effect of anesthetic agents on patients receiving reserpine therapy. Anesthesiology. 1962 Nov-Dec;23:741–746. doi: 10.1097/00000542-196211000-00002. [DOI] [PubMed] [Google Scholar]
  91. Meester W. D., Hardman H. F., Barboriak J. J. Evaluation of various adrenergic blocking agents in isolated rabbit and turtle hearts. J Pharmacol Exp Ther. 1965 Oct;150(1):34–40. [PubMed] [Google Scholar]
  92. Meier M., Wirz E., Brunner H., Stamm W. Effects of norepinephrine and angiotensin II-amide on coronary flow and myocardial oxygen consumption in the cat. Cardiologia. 1965;47(3):127–138. doi: 10.1159/000168384. [DOI] [PubMed] [Google Scholar]
  93. Moss A. J., Vittands I., Schenk E. A. Cardiovascular effects of sustained norepinephrine infusions. 1. Hemodynamics. Circ Res. 1966 May;18(5):596–604. doi: 10.1161/01.res.18.5.596. [DOI] [PubMed] [Google Scholar]
  94. NICKERSON M. VASOCONSTRICTION AND VASODILATATION IN SHOCK. Int Anesthesiol Clin. 1964 Feb;2:385–397. doi: 10.1097/00004311-196402000-00013. [DOI] [PubMed] [Google Scholar]
  95. NISHITH S. D., DAVIS L. D., YOUMANS W. B. Cardioaccelerator action of angiotensin. Am J Physiol. 1962 Feb;202:237–240. doi: 10.1152/ajplegacy.1962.202.2.237. [DOI] [PubMed] [Google Scholar]
  96. OPPENHEIMER M. J., LYNCH P. R., ASCANIO G. Action of mephentermine on arrhythmias due to pulsus alternans, rapidly discharging single atrial foci and prolonged P-R intervals. Am J Physiol. 1957 Dec;191(3):481–486. doi: 10.1152/ajplegacy.1957.191.3.481. [DOI] [PubMed] [Google Scholar]
  97. PAGE I. H., BUMPUS F. M. A new hormone, angiotensin. Clin Pharmacol Ther. 1962 Nov-Dec;3:758–773. doi: 10.1002/cpt196236758. [DOI] [PubMed] [Google Scholar]
  98. PAGE I. H., BUMPUS F. M. Angiotensin. Physiol Rev. 1961 Apr;41:331–390. doi: 10.1152/physrev.1961.41.2.331. [DOI] [PubMed] [Google Scholar]
  99. PEARSON J. W., REDDING J. S. EPINEPHRINE IN CARDIAC RESUSCITATION. Am Heart J. 1963 Aug;66:210–214. doi: 10.1016/0002-8703(63)90036-x. [DOI] [PubMed] [Google Scholar]
  100. POOLER H. E. Atropine, neostigmine and sudden deaths. Anaesthesia. 1957 Apr;12(2):198–202. doi: 10.1111/j.1365-2044.1957.tb03614.x. [DOI] [PubMed] [Google Scholar]
  101. REDDING J. S., PEARSON J. W. Resuscitation from asphyxia. JAMA. 1962 Oct 20;182:283–286. [PubMed] [Google Scholar]
  102. REGAN T. J., LONDON B. L., BINAK K., HELLEMS H. K. Sympathomimetics as antagonists of strophanthidin's ionic and arrhythmic effects. Circ Res. 1962 Jul;11:17–25. [PubMed] [Google Scholar]
  103. REIN J., AUSTEN W. G., MORROW D. H. EFFECTS OF GUANETHIDINE AND RESERPINE ON THE CARDIAC RESPONSES TO HALOTHANE. Anesthesiology. 1963 Sep-Oct;24:672–675. doi: 10.1097/00000542-196309000-00016. [DOI] [PubMed] [Google Scholar]
  104. RIBEILIMA J., WENDT V. E., RAMOS H., GUDBJARNASON S., BRUCE T. A., BING R. J. THE EFFECTS OF NOREPINEPHRINE ON THE HEMODYNAMICS AND MYOCARDIAL METABOLISM OF NORMAL HUMAN SUBJECTS. Am Heart J. 1964 May;67:672–678. doi: 10.1016/0002-8703(64)90338-2. [DOI] [PubMed] [Google Scholar]
  105. RONA G., CHAPPEL C. I., BALAZS T., GAUDRY R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol. 1959 Apr;67(4):443–455. [PubMed] [Google Scholar]
  106. ROSENTHALE M. E., DIPALMA J. R. Acute tolerance to norepinephrine in dogs. J Pharmacol Exp Ther. 1962 Jun;136:336–343. [PubMed] [Google Scholar]
  107. ROSS J., Jr, BRAUNWALD E. THE STUDY OF LEFT VENTRICULAR FUNCTION IN MAN BY INCREASING RESISTANCE TO VENTRICULAR EJECTION WITH ANGIOTENSIN. Circulation. 1964 May;29:739–749. doi: 10.1161/01.cir.29.5.739. [DOI] [PubMed] [Google Scholar]
  108. SAMBHI M. P., WEIL M. H., UDHOJI V. N., SHUBIN H. ADRENOCORTICOIDS IN THE MANAGEMENT OF SHOCK. Int Anesthesiol Clin. 1964 Feb;2:421–433. doi: 10.1097/00004311-196402000-00015. [DOI] [PubMed] [Google Scholar]
  109. SANCETTA S. M. General and pulmonary hemodynamic effects of pure decapeptide angiotensin in normotensive man. Circ Res. 1960 May;8:616–621. doi: 10.1161/01.res.8.3.616. [DOI] [PubMed] [Google Scholar]
  110. SAYEN J. J., KATCHER A. H., SHELDON W. F., GILBERT C. M., Jr The effect of levarterenol on polarographic myocardial oxygen, the epicardial electrocardiogram and contraction in nonischemic dog hearts and experimental acute regional ischemia. Circ Res. 1960 Jan;8:109–128. doi: 10.1161/01.res.8.1.109. [DOI] [PubMed] [Google Scholar]
  111. SCHMIDT J. L., FLEMING W. W. The structure of sympathomimetics as related to reserpine induced sensitivity changes in the rabbit ileum. J Pharmacol Exp Ther. 1963 Feb;139:230–237. [PubMed] [Google Scholar]
  112. SCHMUTZER K. J., RASCHKE E., MALONEY J. V., Jr Intravenous 1-norepinephrine as a casue of reduced plasma volume. Surgery. 1961 Sep;50:452–457. [PubMed] [Google Scholar]
  113. SELZER A., RYTAND D. A. Use of drugs in shock accompanying myocardial infarction. J Am Med Assoc. 1958 Oct 11;168(6):762–768. doi: 10.1001/jama.1958.63000060003012. [DOI] [PubMed] [Google Scholar]
  114. SHIRES G. T., CARRICO C. J., COLN D. THE ROLE OF THE EXTRACELLULAR FLUID IN SHOCK. Int Anesthesiol Clin. 1964 Feb;2:435–454. doi: 10.1097/00004311-196402000-00016. [DOI] [PubMed] [Google Scholar]
  115. SMITH L. L., MOORE F. D. Refractory hypotension in man--is this irreversible shock? N Engl J Med. 1962 Oct 11;267:733–742. doi: 10.1056/NEJM196210112671501. [DOI] [PubMed] [Google Scholar]
  116. SZAKACS J. E., CANNON A. L-Norepinephrine myocarditis. Am J Clin Pathol. 1958 Nov;30(5):425–434. doi: 10.1093/ajcp/30.5.425. [DOI] [PubMed] [Google Scholar]
  117. SZAKACS J. E., MEHLMAN B. Pathologic changes induced by 1-norepineprine: quantitative aspects. Am J Cardiol. 1960 May;5:619–627. doi: 10.1016/0002-9149(60)90127-2. [DOI] [PubMed] [Google Scholar]
  118. Schenk E. A., Moss A. J. Cardiovascular effects of sustained norepinephrine infusions. II. Morphology. Circ Res. 1966 May;18(5):605–615. doi: 10.1161/01.res.18.5.605. [DOI] [PubMed] [Google Scholar]
  119. Shore P. A. The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase. Pharmacol Rev. 1966 Mar;18(1):561–568. [PubMed] [Google Scholar]
  120. Snow P. J. Effect of propranolol in myocardial infarction. Lancet. 1965 Sep 18;2(7412):551–553. doi: 10.1016/s0140-6736(65)90863-9. [DOI] [PubMed] [Google Scholar]
  121. Sodhi H. K., Booker W. M., Bhagat B. The effect of mephentermine on digitalis-induced arrhythmias. Arch Int Pharmacodyn Ther. 1966 May;161(1):132–137. [PubMed] [Google Scholar]
  122. TEXTER E. C., Jr, CHOU C. C., MERRILL S. L., LAURETA H. C., FROHLICH E. D. DIRECT EFFECTS OF VASOACTIVE AGENTS ON SEGMENTAL RESISTANCE OF THE MESENTERIC AND PORTAL CIRCULATION. STUDIES WITH 1-EPINEPHRINE, LEVARTERENOL, ANGIOTENSIN, VASOPRESSIN, ACETYLCHOLINE, METHACHOLINE, HISTAMINE, AND SEROTONIN. J Lab Clin Med. 1964 Oct;64:624–633. [PubMed] [Google Scholar]
  123. UDHOJI V. N., WEIL M. H. CIRCULATORY EFFECTS OF ANGIOTENSIN, LEVARTERENOL AND METARAMINOL IN THE TREATMENT OF SHOCK. N Engl J Med. 1964 Mar 5;270:501–505. doi: 10.1056/NEJM196403052701004. [DOI] [PubMed] [Google Scholar]
  124. UDHOJI V. N., WEIL M. H., SAMBHI M. P. PRESSOR AMINES AND ANGIOTENSIN IN THE TREATMENT OF SHOCK. Int Anesthesiol Clin. 1964 Feb;2:399–419. doi: 10.1097/00004311-196402000-00014. [DOI] [PubMed] [Google Scholar]
  125. Udhoji V. N., Weil M. H. Vasodilator action of a "pressor amine," mephentermine (Wyamine), in circulatory shock. Am J Cardiol. 1965 Dec;16(6):841–846. doi: 10.1016/0002-9149(65)90702-2. [DOI] [PubMed] [Google Scholar]
  126. VANDAM L. D., HARRISON J. H., MURRAY J. E., MERRILL J. P. Anesthetic aspects of renal homotransplantation in man. With notes on the anesthetic care of the uremic patient. Anesthesiology. 1962 Nov-Dec;23:783–792. doi: 10.1097/00000542-196211000-00008. [DOI] [PubMed] [Google Scholar]
  127. VANDAM L. D. THE UNFAVOURABLE EFFECTS OF PROLONGED ANAESTHESIA. Can Anaesth Soc J. 1965 Mar;12:107–120. doi: 10.1007/BF03004086. [DOI] [PubMed] [Google Scholar]
  128. WELCH G. H., Jr, BRAUNWALD E., CASE R. B., SARNOFF S. J. The effect of mephentermine sulfate on myocardial oxygen consumption, myocardial efficiency and peripheral vascular resistance. Am J Med. 1958 Jun;24(6):871–881. doi: 10.1016/0002-9343(58)90340-1. [DOI] [PubMed] [Google Scholar]
  129. WILSON M., PEREZ-ARZOLA M., OPPENHEIMER M. J. Mephentermine and the arrhythmias. Am J Med Sci. 1958 Sep;236(3):300–310. [PubMed] [Google Scholar]
  130. YU P. N., LURIA M. N., FINLAYSON J. K., STANFIELD C. A., CONSTANTINE H., FLATLEY F. J. The effects of angiotensin on pulmonary circulation and ventricular function. Circulation. 1961 Dec;24:1326–1337. doi: 10.1161/01.cir.24.6.1326. [DOI] [PubMed] [Google Scholar]
  131. YURCHAK P. M., ROLETT E. L., COHEN L. S., GORLIN R. EFFECTS OF NOREPINEPHRINE ON THE CORONARY CIRCULATION IN MAN. Circulation. 1964 Aug;30:180–187. doi: 10.1161/01.cir.30.2.180. [DOI] [PubMed] [Google Scholar]
  132. ZIEGLER C. H., LOVETTE J. B. Operative complications after therapy with reserpine and reserpine compounds. JAMA. 1961 Jun 17;176:916–919. doi: 10.1001/jama.1961.03040240022009. [DOI] [PubMed] [Google Scholar]
  133. ZIMMERMAN B. G., ABBOUD F. M., ECKSTEIN J. W. Comparison of the effects of sympathomimetic amines upon venous and total vascular resistance in the foreleg of the dog. J Pharmacol Exp Ther. 1963 Mar;139:290–295. [PubMed] [Google Scholar]
  134. ZUCKER G., EISINGER R. P., FLOCH M. H., SINGER M. M. Treatment of shock and prevention of ischemic necrosis with levarterenol-phentolamine mixtures. Circulation. 1960 Nov;22:935–937. doi: 10.1161/01.cir.22.5.935. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES